Amiodarone effectively treats a wide range of tachycardias but should always be prescribed with caution. Here are 3 key points to remember.
VIDEO: In a Medical News Minute, a topline review of the AHA's comprehensive guide to risk reduction in HF patients.
Drugs that improve blood pressure may have negative effects on a wide range of common comorbidities.
A new study assessed the poorly understood impact of pulmonary hypertension on mortality after myocardial infarction.
This short slide show highlights new drugs now recommended, a new HF category, and recommendations for optimizing treatment.
Researchers presented several new findings about statins and non-statins at ACC.16. This brief roundup summarizes these and other noteworthy reports.
Highlights of four recent studies in hypertension, heart failure, preeclampsia expose vulnerable populations.
PCSK9-I Patient Population and Potential  FDA-approved for relatively small patient group w/ uncontrolled LDL despite max therapy and at high risk for CVD. Familial hypercholesterolemia: ~620,000 in US.
One of the biggest advances in the world of nonvalvular atrial fibrillation was the introduction of the novel oral anticoagulants (NOACs) for decreasing thromboembolic risk.
Atrial fibrillation (AF) may increase the risk of dementia, according to a new study conducted in the Netherlands. The study looked at 20 years of follow-up data on over 6000 people, and found that younger participants with a longer duration of AF had the highest risk of dementia.